Curi RMB Capital LLC Increases Position in Abacus Life, Inc. (NASDAQ:ABL)

Curi RMB Capital LLC lifted its position in shares of Abacus Life, Inc. (NASDAQ:ABL) by 2.4% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 550,000 shares of the company’s stock after buying an additional 12,765 shares during the quarter. Curi RMB Capital LLC owned approximately 0.74% of Abacus Life worth $5,566,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of ABL. Evernest Financial Advisors LLC bought a new position in Abacus Life in the 3rd quarter worth approximately $681,000. Principal Financial Group Inc. bought a new position in shares of Abacus Life during the second quarter worth $8,105,000. Mendon Capital Advisors Corp purchased a new position in Abacus Life during the second quarter valued at $4,974,000. Clearbridge Investments LLC purchased a new position in Abacus Life during the second quarter valued at $4,342,000. Finally, Richard W. Paul & Associates LLC increased its holdings in Abacus Life by 4.8% in the 2nd quarter. Richard W. Paul & Associates LLC now owns 30,448 shares of the company’s stock valued at $263,000 after acquiring an additional 1,401 shares during the last quarter.

Abacus Life Stock Down 3.1 %

NASDAQ:ABL opened at $8.48 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65. The business has a 50 day simple moving average of $9.49 and a 200-day simple moving average of $9.99. Abacus Life, Inc. has a 1 year low of $5.85 and a 1 year high of $13.25.

Abacus Life (NASDAQ:ABL) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.06. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The company had revenue of $28.15 million during the quarter, compared to the consensus estimate of $26.08 million. During the same period last year, the company earned $0.01 earnings per share. As a group, research analysts anticipate that Abacus Life, Inc. will post 0.6 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. B. Riley Financial restated a “buy” rating and set a $16.00 price objective on shares of Abacus Life in a research report on Friday, August 30th. B. Riley restated a “buy” rating and set a $16.00 price target (up previously from $15.00) on shares of Abacus Life in a report on Thursday, August 29th. Northland Securities assumed coverage on Abacus Life in a research note on Thursday, October 24th. They issued an “outperform” rating and a $13.50 price objective on the stock. Piper Sandler reiterated an “overweight” rating and set a $13.00 target price (up from $12.00) on shares of Abacus Life in a research report on Friday, November 8th. Finally, Northland Capmk upgraded shares of Abacus Life to a “strong-buy” rating in a research report on Thursday, October 24th. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Abacus Life presently has an average rating of “Buy” and an average price target of $14.50.

Abacus Life Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.